Unichem Laboratories receives USFDA approval for Irbesartan Tablets

17 Oct 2012 Evaluate

Unichem Laboratories has received ANDA tentative approval from the United States Food and Drugs Administration (USFDA) for Irbesartan. Final approval will be received after the patent expires on Dec 7, 2015. 

Irbesartan Tablets 75mg, 150mg and 300mg are therapeutically equivalent to Avapro Tablets 75mg, 150mg and 300mg from Sanofi Aventis US, LLC. Irbesartan is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

The product will be commercialized (after the final approval) from Unichem's Ghaziabad plant, Active pharmaceutical ingredient i.e., Irbesartan used for this ANDA is also made in house at Pithampur plant. The current market size is $450 million.

Unichem Laboratories, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Unichem Lab Share Price

439.15 -8.00 (-1.79%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×